Research map: Subclass switching enhances protective efficacy of a non-neutralizing H7N9 avian influenza antibody

Back to the article

Papers in this map

  1. Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus · Rongbao Gao · 2013 · 2359 citations · Cited by this paper
  2. YgeP, a global regulator within the ETT2 pathogenicity island, coordinates motility-biofilm balance and negatively controls serum resistance in avian pathogenic Escherichia coli · 2026 · Related
  3. Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity · Robert L. Shields · 2002 · 1850 citations · Cited by this paper
  4. Large-scale whole-genome sequencing of animal clinical Salmonella enterica demonstrates relatedness to human cases · 2026 · Related
  5. Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity · Pablo Umaña · 1999 · 768 citations · Cited by this paper
  6. Metagenomic sequencing provides insight into pathogenic and related benign microbes in ticks collected from pastured cattle · 2026 · Related
  7. Mouse and human FcR effector functions · Pierre Bruhns · 2015 · 585 citations · Cited by this paper
  8. CAV1 up-regulated by peste des petits ruminants virus nucleocapsid protein impairs type I IFN response by cholesterol synthesis · 2026 · Related
  9. Fucose Depletion from Human IgG1 Oligosaccharide Enhances Binding Enthalpy and Association Rate Between IgG1 and FcγRIIIa · Akira Okazaki · 2004 · 342 citations · Cited by this paper
  10. Soluble triggering receptor expressed on myeloid cells 2 restrained PRRSV replication via interfering PRRSV binding and activating NF-ĸB pathway · 2026 · Related
  11. Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013–17: an epidemiological study of laboratory-confirmed case series · Xiling Wang · 2017 · 291 citations · Cited by this paper
  12. MARCH8 inhibits PRRSV-2 replication by targeting viral GP5 for proteasomal degradation at a conserved lysine 163 · 2026 · Related
  13. Antibodies to combat viral infections: development strategies and progress · Giuseppe Pantaleo · 2022 · 289 citations · Cited by this paper
  14. Infection dynamics and disease prevalence of Chlamydia pecorum in koalas across two geographically separated habitats in Southeast Queensland · 2026 · Related
  15. Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection · Carole J. Henry Dunand · 2016 · 284 citations · Cited by this paper
  16. African swine fever virus E301R protein promotes RIG-I autophagic degradation by enhancing RIG-I-sequestosome-1 interaction · 2026 · Related
  17. Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA · Katsuhiro Mori · 2004 · 175 citations · Cited by this paper
  18. HtpsB, a type II histidine triad protein of Streptococcus suis, contributes to bacterial virulence and blood-brain barrier disruption · 2026 · Related
  19. Antiviral neutralizing antibodies: from in vitro to in vivo activity · Dennis R. Burton · 2023 · 165 citations · Cited by this paper
  20. A novel oral prodrug (CK301) for effusive feline infectious peritonitis: An open-label study evaluating dose optimization and therapeutic efficacy · 2026 · Related
  21. Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection · Gene S. Tan · 2016 · 156 citations · Cited by this paper
  22. Emerging H7N9 Influenza A (Novel Reassortant Avian-Origin) Pneumonia: Radiologic Findings · Qingle Wang · 2013 · 85 citations · Cited by this paper
  23. Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity · James T. Earnest · 2019 · 80 citations · Cited by this paper
  24. Effector mechanisms of influenza-specific antibodies: neutralization and beyond · Federica Sicca · 2018 · 55 citations · Cited by this paper
  25. Fc functional antibodies in humans with severe H7N9 and seasonal influenza · Hillary A. Vanderven · 2017 · 52 citations · Cited by this paper
  26. Human monoclonal antibodies as candidate therapeutics against emerging viruses · Yujia Jin · 2017 · 51 citations · Cited by this paper
  27. Evolution of H7N9 highly pathogenic avian influenza virus in the context of vaccination · Yujie Hou · 2024 · 44 citations · Cited by this paper
  28. Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions · Camille N. Pierre · 2024 · 37 citations · Cited by this paper
  29. Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of H7N9 Influenza Viruses · Zhihao Sun · 2018 · 35 citations · Cited by this paper
  30. Short‐hairpin‐RNA‐mediated silencing of fucosyltransferase 8 in Chinese‐hamster ovary cells for the production of antibodies with enhanced antibody immune effector function · Vincent Beuger · 2008 · 32 citations · Cited by this paper
  31. Human infection with a novel avian-origin influenza A (H7N9) virus: serial chest radiographic and CT findings · Jian Dai · 2014 · 27 citations · Cited by this paper
  32. Subclass-switched anti-spike IgG3 oligoclonal cocktails strongly enhance Fc-mediated opsonization · Arman Izadi · 2023 · 26 citations · Cited by this paper
  33. Antibody Immunity Induced by H7N9 Avian Influenza Vaccines: Evaluation Criteria, Affecting Factors, and Implications for Rational Vaccine Design · Zenglei Hu · 2017 · 17 citations · Cited by this paper
  34. Tackling a novel lethal virus: a focus on H7N9 vaccine development · Irina N. Isakova-Sivak · 2017 · 15 citations · Cited by this paper
  35. Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations · Teha Kim · 2025 · 9 citations · Cited by this paper
  36. Mutations during the adaptation of H7N9 avian influenza virus to mice lungs enhance human-like sialic acid binding activity and virulence in mice · Guoqing Wang · 2021 · 8 citations · Cited by this paper
  37. Expression and characterization of a recombinant broadly-reactive monoclonal antibody against group 1 and 2 influenza viruses · Zenglei Hu · 2022 · 2 citations · Cited by this paper
  38. Antibodies elicited by Newcastle disease virus-vectored H7N9 avian influenza vaccine are functional in activating the complement system · Zenglei Hu · 2023 · 2 citations · Cited by this paper
  39. Direct airway delivery of a humanized anti-H7N9 neutralizing antibody broadly protects against divergent H7 influenza viruses in the mouse model · Yu Wang · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)